Core Business Tracks
◆Financial licensing, technology, and healthcare form our core M&A focus—capturing Japan’s most resilient growth opportunities.
Securities firms, financial services, and fintech. We navigate Japan–China regulatory frameworks and deal structures to secure scarce, high-barrier licenses and expand addressable markets.
System development, SaaS, AI, and digital transformation (DX). Our in-house tech team delivers code-level technical due diligence and deploys proprietary AI to create post-acquisition value.
Aging-society demand: clinics and healthcare IT. We build “financial services + IT data + healthcare delivery” ecosystems to secure stable cash flow.
Our Value
HaoHao is built on integrity, innovation, expertise, and growth. We believe lasting value comes not only from precise financial investment but from deep technical enablement. By combining institutional-grade capital execution with Zeyu Tech’s AI and communications infrastructure, we build durable moats for portfolio companies.
01
Fund-level management and post-acquisition integration experience. From due diligence to exit, we apply the highest standards of financial and compliance control to every cross-border transaction.
02
Beyond traditional M&A. Our in-house IT team deploys Zeyu’s Doni AI knowledge systems to create enterprise-grade intelligence at the core of portfolio companies.
03
For healthcare and regulated financial services we deploy FreeSWITCH-based MCU video and MyCard digital communications to create enterprise-grade data boundaries.
04
We build “financial services + IT data + healthcare” ecosystems. Bilingual executives and technical experts drive portfolio companies toward long-term strategic outcomes.
About HaoHao
Real value lies in the alignment of technology and business model, not only in financial metrics. As a platform spanning financial services, TMT, and healthcare, we partner with Zeyu Tech to bring three decades of development expertise and Doni AI solutions to Japan, driving Asian enterprises forward.
100%
Capital & Technology Enablement
Why Choose Us
Over 12 years of international investment experience across Japan, China, Hong Kong, Singapore, and the US. We provide full-lifecycle services from sourcing and due diligence to post-acquisition value creation—not just intermediation.
Track Record
Deep in Japan’s core markets, HaoHao combines capital strength with proprietary IT enablement to advance cross-border M&A and integration in financial licensing, TMT, and healthcare & life sciences.
Tokyo-based institution with scarce Type 1 license; valuation in excess of ¥1.5B. We are planning post-acquisition compliance expansion and digital finance upgrade.
Tech staffing and system development; valuation in excess of ¥800M. Our technical due diligence identified AI product potential; we plan to deploy industrial IoT post-close.
Tokyo-based advanced care provider; precision checkups and stem cell therapy; valuation in excess of ¥3B. Future integration of consumer finance and digital healthcare services.
With Zeyu Tech we deploy enterprise RAG knowledge bases and secure MCU video for acquired Japanese companies—rebuilding competitiveness from the infrastructure layer.
Our Process
From sector insight to post-acquisition value creation, we advance every step—sourcing, due diligence, valuation, negotiation, and closing—to institutional standards.
01
Sector research and preliminary regulatory dialogue. NDA execution, business model assessment, and initial valuation.
02
International legal and financial DD. In-house technical team performs code and architecture assessment.
03
Leverage, tax planning, and risk mitigation. Core documentation negotiation and cross-border financing to close.
04
Board-level oversight and financial control. Deployment of digital IT and AI solutions; path to exit.
FAQ
Key questions on HaoHao’s investment approach, due diligence process, and technology enablement—answered with clarity and depth.
Interested in working together? — Contact the investment team
Market Insights
In-depth analysis of the Japan market and HaoHao’s experience in financial licensing, TMT, and life sciences—due diligence and post-acquisition value creation.